Preprint Article Version 1 This version is not peer-reviewed

FKBP5 Polymorphism, Coping and Emotional Status in Chronic Obstructive Pulmonary Disease Patients Undergoing Pulmonary Rehabilitation

Version 1 : Received: 4 July 2019 / Approved: 8 July 2019 / Online: 8 July 2019 (03:36:21 CEST)

How to cite: Prinzi, G.; Tomino, C.; Santoro, A.; Marcolongo, F.; Cardaci, V.; Fini, M.; Giacconi, R.; Malavolta, M.; Provinciali, M.; Ricci, A.; Bonassi, S.; Russo, P. FKBP5 Polymorphism, Coping and Emotional Status in Chronic Obstructive Pulmonary Disease Patients Undergoing Pulmonary Rehabilitation. Preprints 2019, 2019070097 (doi: 10.20944/preprints201907.0097.v1). Prinzi, G.; Tomino, C.; Santoro, A.; Marcolongo, F.; Cardaci, V.; Fini, M.; Giacconi, R.; Malavolta, M.; Provinciali, M.; Ricci, A.; Bonassi, S.; Russo, P. FKBP5 Polymorphism, Coping and Emotional Status in Chronic Obstructive Pulmonary Disease Patients Undergoing Pulmonary Rehabilitation. Preprints 2019, 2019070097 (doi: 10.20944/preprints201907.0097.v1).

Abstract

Background: COPD is characterized by dyspnea, chronic cough, sputum production and extra pulmonary multimorbidity including depression, anxiety and cognitive problems. Methods: Cognitive and psychological clinical alterations/disorders; QoL/Health-related QoL; and Coping strategies were evaluated in 71 COPD patients characterized for FKBP5 gene (rs4713916). Instruments: MMSE, MoCA, ROCF, BDI-II, CES-D, SAS, SF-36, ADL, IADL, SGRQ, MRF 26, CIRS, Brief COPE. Results: Carriers of the rs4713916 polymorphisms (G:A) show better cognitive performances, higher degree of independence in the ADL and IADL, better QoL before and after rehabilitation, no presence of depressive mood and anxiety symptoms, no family history of psychiatric disorder, more ability to cope with stressors by avoiding emotions but demanding emotional support, and lesser use of anti-anxiety, anti-depressant anti-psychotic, hypnotic-sedative drugs. On the other hand, no difference was found as regards the number of comorbidities. Conclusions: Our study shows that rs4713916 is positively associated with better outcome for COPD. These results offer valuable insights into the role of FKBP5 in the complex network of mechanisms associated to clinical and behavioral features of COPD patients.. Our data may be used as initial benchmark for future clinical studies.

Subject Areas

anxiety; COPD; coping strategies; corticosteroid; depression; rehabilomics; rs471396

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.